Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma
- Resource Type
- Article
- Source
- In
Annals of Oncology January 2004 15(1):64-69 - Subject
- Language
- ISSN
- 0923-7534